Internal Advisory Committee Along with Drs. Ahles, Hubbard, Gany and Trevisan, members of the Internal Advisory Committee (IAC) provide major academic leadership and support for the Partnership. The members of the IAC have diverse backgrounds that map onto areas of strength in our translational research and training portfolio: health disparities, biomedical engineering, and basic science. The IAC will meet quarterly to review progress of research projects and training and outreach cores, and will have oversight responsibility of effective mentorship of junior faculty and trainees. The IAC will also be actively involved in the identification of external reviewers for grants submitted for consideration for U54 funding, and decision-making regarding which grants to fund following external review. Program Steering Committee The Program Steering Committee (PSC) will continue to meet annually, about six to eight weeks before the annual progress report is due, to review the progress and priorities of our Partnership. We will also hold an annual teleconference (more as needed) with the PSC to keep members up to date and to discuss emerging opportunities and issues. We are fortunate to have retained six of our seven members of our Program Steering Committee (Drs. Ozer, Bayliss, Munn, Vernon, Trickett, and Lepore). Only Dr. Gany has left the PSC, since she joined MSKCC and is now co-PI of the Partnership at MSKCC. Several of these senior scientists have been guiding us since we prepared our U56 proposal in 2001 and the subsequent U54, and have been instrumental in reviewing our work at every stage of development of the U54. In addition, we have allocated funds for various ad hoc members to join the PSC as needed, as our transdisciplinary work in cancer disparities takes shape and direction. Executive Advisory Committee During the U54 we formed an Executive Advisory Committee to ensure that the Partnership was fully integrated into CCNY and MSKCC institutional priorities and to address the Partnership's needs. We will continue to meet with our Executive Advisory Committee annually, bringing together senior leadership from both MSKCC and CCNY to discuss relevant developments, opportunities and concerns. Although the senior leadership at both MSKCC and CCNY have changed during the U54, we have engaged the new President of CCNY and new Physician-in-Chief at MSKCC, both of whom agreed join our Executive Advisory Committee

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA137788-07
Application #
8764995
Study Section
Special Emphasis Panel (ZCA1-SRLB-Y)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
7
Fiscal Year
2014
Total Cost
$41,591
Indirect Cost
$16,173
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Nicolas, Laura; Cols, Montserrat; Choi, Jee Eun et al. (2018) Generating and repairing genetically programmed DNA breaks during immunoglobulin class switch recombination. F1000Res 7:458
Juarez, Michelle T; Kenet, Chloe M (2018) Translating Research as an Approach to Enhance Science Engagement. Int J Environ Res Public Health 15:
Takahashi, Yusuke; Eguchi, Takashi; Kameda, Koji et al. (2018) Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance. Oncotarget 9:35742-35751
Zheng, Simin; Kusnadi, Anthony; Choi, Jee Eun et al. (2018) NME proteins regulate class switch recombination. FEBS Lett :
Burkhalter, Jack E; Atkinson, Thomas M; Berry-Lawhorn, J et al. (2018) Initial Development and Content Validation of a Health-Related Symptom Index for Persons either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions. Value Health 21:984-992
Ayash, Claudia; Costas-Muñiz, Rosario; Badreddine, Dalal et al. (2018) An Investigation of Unmet Socio-Economic Needs Among Arab American Breast Cancer Patients Compared with Other Immigrant and Migrant Patients. J Community Health 43:89-95
Li, Guang; Sun, August; Nie, Xingyu et al. (2018) Introduction of a pseudo demons force to enhance deformation range for robust reconstruction of super-resolution time-resolved 4DMRI. Med Phys 45:5197-5207
Srimathveeravalli, Govindarajan; Abdel-Atti, Dalya; Pérez-Medina, Carlos et al. (2018) Reversible Electroporation-Mediated Liposomal Doxorubicin Delivery to Tumors Can Be Monitored With 89Zr-Labeled Reporter Nanoparticles. Mol Imaging 17:1536012117749726
Del Ferraro, Gino; Moreno, Andrea; Min, Byungjoon et al. (2018) Finding influential nodes for integration in brain networks using optimal percolation theory. Nat Commun 9:2274
Kodama, Hiroshi; Vroomen, Laurien G; Ueshima, Eisuke et al. (2018) Catheter-based endobronchial electroporation is feasible for the focal treatment of peribronchial tumors. J Thorac Cardiovasc Surg 155:2150-2159.e3

Showing the most recent 10 out of 156 publications